Several high-profile partnerships between pharma and AI companies have materialized recently, but with commercial validation of approaches taking place, improving technologies will expedite this process. The AI Driven Drug Discovery Summit Europe will highlight key approaches to implementing novel AI technologies to expanding datasets. With this landscape rapidly evolving, the need to determine where and how AI can most add value has never been stronger. By uniting leaders from pharma, biotech, AI-technology companies and academia, this forum allows you to create a clear strategic vision and ambition regarding the use of AI to optimise drug discovery. This executive event reveals the latest technology upgrading the day-to-day tool kit of drug developers and data scientists spanning the pharmaceutical landscape. Understand how you can harness cutting-edge tools that provide discoverable, accessible, and transformable data analytics to guide your workflow, reducing costs, and informing decisions. Meet senior experts from start-ups to pharmaceutical giants and unlock the full potential of AI/ML platforms that are reshaping drug design, optimisation, and screening. Find out how to upgrade your presence and platform your AI services – based on your objectives we can create custom bespoke packages designed specifically for you.

Read on aidrugdevelopmentsummiteu.com

Microbiology remains an essential tool in reducing microbial growth in the manufacture of pharmaceuticals, to detect and eliminate microorganisms that would pose a risk to patients and jeopardise product batches.

Ensuring the sterility of the finished product continues to be one of the most critical aspects of drug development, however an array of factors is also sustaining new growth and transformation in this field. The regulatory landscape is changing, firstly with the preparation of Annex I, in addition to increasing requirements pertaining to data integrity. 

 Read on go.evvnt.com

Microbiology remains an essential tool in reducing microbial growth in the manufacture of pharmaceuticals, to detect and eliminate microorganisms that would pose a risk to patients and jeopardise product batches.

Ensuring the sterility of the finished product continues to be one of the most critical aspects of drug development, however an array of factors is also sustaining new growth and transformation in this field. The regulatory landscape is changing, firstly with the preparation of Annex I, in addition to increasing requirements pertaining to data integrity. Light is being shed on recent product recalls for mould contamination, and infection outbreaks serve as a reminder to pay more attention to these overlooked organisms, as well as considerations towards container closure integrity testing which is being increasingly deployed to block microbe movement.

On top of this, the developing integration of automation and robotics into the manufacturing pipeline, as well as the increased need for more rapid microbiology methods brought about in part by the surge in ATMPs, are all highlighting the necessity of the field in Pharma.

This industry is ever expanding, join our leading experts at the 6th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA to discuss and analyse the latest advances and challenges surrounding Pharmaceutical Microbiology. Network with the industry professionals, discuss revisions in regulatory and guidance documents, and gain a deeper insights.

Read on go.evvnt.com

Accelerating Biomarker-Driven Drugs into Clinical Trials Whilst Strategising Your CDx Development, IVDR Compliance and Commercialisation Path to Improve Clinical Decision-Making and Patient Outcomes

The 13th Clinical Biomarkers and CDx Europe 2023 returns as the premier European forum for end-to-end discussions, actionable insights, and partnership development to guide biomarker discovery and companion diagnostics (CDx) development programmes as they progress toward commercialisation.

Read on go.evvnt.com

The World Oncology Cell Therapy Congress is the only annual meeting bringing together drug developers, investors, solution providers and clinicians whose purpose is to deliver safe and effective adoptive cell therapy products to clinical implementation.  For 2023, we have revamped and repositioned the schedule to reflect the dynamic research environment of the cell therapy field.  Enjoy an exclusive pre-event evening networking session centred around overcoming barriers to patient access and facilitating clinical distribution of transformative cell therapy products. 

Our on-stage talks, panels and Q&As will come under the following themes:  

• Breakthroughs and Pipeline Advancements 
• New Cell Therapy Platforms and Enabling Technologies 
• Manufacturing at Scale and Commercialization 
• Pre-event evening expanding into Cell Therapy Access 

Read on oncocelltherapy.com

Today's healthcare landscape is more complex than ever before. Clinicians and organizations are looking for the most efficient, cost-effective and secure ways to connect the dots between groundbreaking healthcare technology and compliance or cybersecurity challenges. In this discussion, industry experts will share best practices for balancing digital transformation efforts with EHR compliance requirements. Experts will also discuss how patient satisfaction and better patient outcomes are directly tied to the ease of accessibility of EHRs for both patients and healthcare providers.

Learning points:

• How increased patient satisfaction is directly tied to EHR, including secure patient access of data that is portable and compliant
• How to avoid EHR adoption hurdles
• Cost-effective EHR hosting to ensure scalability
• How to overcome data migration and privacy hurdles

Read on go.beckershospitalreview.com

Healthcare leaders cannot build an effective staffing strategy without understanding what nurses want and how their needs are changing. Discover the latest insights into the nursing industry with Incredible Health's 4th Annual State of Nursing Report. This year's report is based on data of over 700,000 nurses, as well as survey responses from more than 3,000 nurses. During this webinar, experts will share the report's key findings and offer practical guidance on how you can apply these insights to your hospital or health system.

Some of the results include:

• Why 80 percent of nurses plan to stay in nursing until retirement
• Why an increasing number of nurses say hospitals aren't changing fast enough
• The percentage of nurses that say they'll change jobs in 2023
• The primary factors nurses consider before a role change

Read on go.beckershospitalreview.com

The in-person event will provide the opportunity to hear from high-level policymakers and stakeholders on key themes surrounding the digital health domain (e.g. electronic prescription and health data sharing), both from the EU and national perspective. Being at the core of the political debate, the European Health Data Space (EHDS) will be the main topic discussed by the panel. As a common European regulatory framework for the sharing of health data for primary (healthcare providers) and secondary (research and innovation) uses, the EHDS will have a major impact on the national and regional level. As innovative healthcare providers, with sound experience in providing high-quality national and cross-border digital health services, online pharmacies can contribute to making the EHDS a success. As the event will take place at the heart of German policymaking, a dedicated panel discussion – next to showcasing benefits and experiences of other EU countries – will be aimed at taking stock of the implementation of electronic prescription in Germany as well as future scenarios.

Read on echalliance.com

n this webinar, learn how Penn State built a sustainable workforce plan to improve patient care through extreme challenges and fluctuations in the market. They’ll share the importance of using real-time data for informed critical decision-making processes and how technology can ensure the right number of RNs with the right skills are employed in the right place at the right time. The workforce and financial challenges of today can impact a health care system’s ability to care for its community. It is imperative for health care leaders to optimize the resources they have today and build the workforce for tomorrow. To do that requires redesigning processes, developing new strategies and implementing technologies to strategically allocate staffing resources to meet patient needs.    

Read on aha.org

This conference will introduce and explore various approaches to managing acute and chronic pain including holistic and pharmacologic interventions. Nurses and other care providers interact with individuals with all types of pain across the healthcare continuum. Topics include chronic pain management across care settings, integrative therapies, disparities and inequities in treating pain, medical cannabis, and a patient's journey.

3.00 ANCC hours apply toward advanced practice nursing pharmacology credits.

13.75 ANCC contact hours meet ACHPN® HPAR and ASPMN® continuing education requirements for recertification.

Upon completion of this activity, participants should be able to:

-Explore the management of acute and chronic pain

-Describe integrative approaches to pain management

-Discuss pharmacologic interventions related to pain management and withdrawal

-Outline disparities and inequities in treating pain

Price:

Conference Admission: USD 600.00

Dates and Time: Starts: Tue, Apr 25, 2023 ( 7:00 AM) and Ends: Wed, Apr 26, 2023 ( 5:00 PM)

Venue details: Hilton Rochester Mayo Clinic Area, 10 East Center Street, Rochester, Minnesota, 55904, United States